TMCnet News
US Respiratory Disease Diagnostics Market Shares and Segment Forecasts 2017-2021: Emerging Opportunities and Growth Strategies for Suppliers - ResearchAndMarkets.comThe "US Respiratory Disease Diagnostics Market Shares and Segment Forecasts 2017-2021: Emerging Opportunities and Growth Strategies for Suppliers" report has been added to ResearchAndMarkets.com's offering This new 283-page report presents detailed analysis of the US Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis. The report provides test volume and sales projections for Hospitals, Physician Offices, Commercial, and Public Health Labs. In addition to market share and sales forecasts, the report:
Key Topics Covered: A. Major Infectious Disease Tests 1. Adenovirus 2. Influenza Viruses 3. Legionella 4. Mononucleosis 5. Mycoplasma 6. Pneumonia 7. Respiratory Syncytial Virus (RSV) 8. Tuberculosis B. Instrumentation Review of Leading Analyzers Marketed by Abbott, Beckman Coulter/Danaher (News - Alert), BioMerieux, Ortho-Clinical Diagnostics, Roche, Siemens, Tosoh, Wallac and Other Suppliers C. Emerging Diagnostic Technologies 1. Molecular Diagnostics 2. Monoclonal Antibodies 3. Immunoassays 4. Differential Light Scattering 5. Information Technology 6. Artificial Intelligence 7. Liposomes 8. Flow Cytometry 9. Chromatography 10. Diagnostic Imaging 11. Gel Microdroplets 12. Other Competitive Assessments
For more information about this report visit https://www.researchandmarkets.com/research/5hqwdf/us_respiratory?w=4 View source version on businesswire.com: http://www.businesswire.com/news/home/20180214006224/en/ |